George Triadafilopoulos
Publication Details
-
Cost-effectiveness model of endoscopic screening and surveillance in patients with gastroesophageal reflux disease.
Clin Gastroenterol Hepatol. 2004; (10): 868-79
Endoscopic screening and periodic surveillance for patients with Barrett's esophagus has been shown to be cost-effective in patients with esophageal dysplasia, with treatment for esophageal cancer limited to esophagectomy. Most gastroenterologists refer patients with high-grade dysplasia for esophagectomy, and effective endoscopic therapies are available for nonoperative patients with esophageal cancer. The cost-effectiveness of screening strategies that incorporate these nonsurgical treatment modalities has not been determined.
Help
Trial Administration